SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Shaw who wrote (85)10/15/1996 7:38:00 PM
From: Tara Cobble   of 1154
 
Can anybody verify this information that I was provided. I can not guarantee this is true but I believe it is and would appreciate a little due dilly to verify on Reuters or somewhere.

It is my understanding that another brokerage firm Aegis Capital put out a Buy recommendation on GENE Friday 10/11 with a 12 month target of $20. It sure seems like more firms are quoting numbers in that area, this may have been the thing that helped bounce GENE back up.
Tara (other info. to be posted on Arris Pharm. and Aronex threads)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News